Respiratory

Latest News

ILD | Image Credit: PH alex aviles - stock.adobe.com
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening

November 20th 2024

This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.

ISM001-055 is a novel drug developed through generative AI biotechnology | image credit: ipopba - stock.adobe.com
Novel, AI-Procured ISM001-055 Demonstrates Great Promise for Treatment of IPF

November 12th 2024

Nurses during COVID-19 experience burnout | Image Credit: Nina Lawrenson/peopleimages.com - stock.adobe.com
COVID-19 Leaves Lasting Impact on Nursing Practices and Job Satisfaction

October 31st 2024

IPF diagnosis | Image credit: Vitalii Vodolazskyi - stock.adobe.com
FIBRONEER-IPF Trial of Nerandomilast Meets Primary End Point

September 19th 2024

AI robot thinking | Image credit: phonlamaiphoto – stock.adobe.com
Are AI-Powered Robots the Future of Respiratory Health Care?

September 17th 2024

Continuing Medical Education
View All
November 21st 2024

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

Investigating Manual Therapy as a Treatment for COPD
February 14th 2019

Investigating Manual Therapy as a Treatment for COPD

Wallace Stephens
There is not enough evidence that manual therapy—a clinical approach of using skilled, physical, hands-on procedures to improve function, lessen pain, and facilitate movement—can successfully be used to treat chronic obstructive pulmonary disease (COPD).
High-Dose Liquid Birch Pollen Extract Safely Reduced Symptoms in Adults With Pollen Allergies, Trial Results Show
December 29th 2018

High-Dose Liquid Birch Pollen Extract Safely Reduced Symptoms in Adults With Pollen Allergies, Trial Results Show

Jackie Syrop
Patients with allergies to birch pollen who took drops of birch pollen extract under the tongue for 3 to 6 months were able to reduce their symptoms and improve their quality of life.
CDC Issues Alert on Resurgence of Progressive Massive Fibrosis in Coal Miners
December 27th 2018

CDC Issues Alert on Resurgence of Progressive Massive Fibrosis in Coal Miners

Jackie Syrop
CDC noted a rise in black lung disease, a potentially lethal disease, with a new report of a cluster of 60 cases identified in former and current coal miners at a single eastern Kentucky radiologist’s practice from January 2015 to August 2016.
Focusing on High-Risk Patients With TB May Help Eliminate the Disease in US
December 22nd 2018

Focusing on High-Risk Patients With TB May Help Eliminate the Disease in US

Jackie Syrop
Focusing on patients with latent tuberculosis (TB) infection who are at high risk of developing active TB may be key to eliminating the disease in the United States; however, a study found that physicians are not systematically identifying risk levels for patients with latent TB.
Preventing Wheezing/Asthma Attacks in Preschool Children
December 21st 2018

Preventing Wheezing/Asthma Attacks in Preschool Children

Jackie Syrop
Researchers found no evidence that initiation of inhaled corticosteroids or leukotriene receptor antagonist therapy is associated with fewer wheezing/asthma attacks than therapy with a short-acting ß-agonist alone in preschool children with recurrent wheezing/asthma.
Assessing Physician Awareness, Management of Coexisting Asthma and Allergic Rhinitis in Asia-Pacific Region
December 21st 2018

Assessing Physician Awareness, Management of Coexisting Asthma and Allergic Rhinitis in Asia-Pacific Region

Jackie Syrop
While there is widespread acceptance of the coexistent asthma–AR and the associated burden among physicians, a new study highlighted the need for increased healthcare practitioner communication and awareness to improve the appropriate treatment and management of these 2 coexistent conditions.
Nontuberculous Mycobacterial Lung Disease Doubled the Risk of Death in a Managed Care Population
December 14th 2018

Nontuberculous Mycobacterial Lung Disease Doubled the Risk of Death in a Managed Care Population

Jackie Syrop
A new study examining the public health burden of nontuberculous mycobacterial lung disease in the United States has found that all-cause mortality, adjusted for other factors, more than doubled with NTMLD compared with an age- and sex-matched control group.
Duration of Disturbed Breathing During Sleep Predicts Mortality
December 13th 2018

Duration of Disturbed Breathing During Sleep Predicts Mortality

Jackie Syrop
How long a person with obstructive sleep apnea (OSA) stops breathing may be a better predictor of mortality risk from OSA in both women and men than the number of times they stop breathing, a new study published in the American Journal of Respiratory and Critical Care Medicine concludes.
Promising Testing Tool Can Provide Accurate Diagnosis of Lower Respiratory Infections
December 8th 2018

Promising Testing Tool Can Provide Accurate Diagnosis of Lower Respiratory Infections

Jackie Syrop
A next generation DNA sequencing study offers a streamlined protocol that integrates the genomic portrait of pathogen, microbiome, and host transcriptome for a more accurate diagnosis of lower respiratory tract infections.
Baseline Factors Can Identify Positive Response to Benralizumab in Severe Asthma
December 7th 2018

Baseline Factors Can Identify Positive Response to Benralizumab in Severe Asthma

Jackie Syrop
A study published in the European Respiratory Journal suggests that in addition to elevated blood eosinophil counts, baseline clinical factors can help identify patients who would potentially be responsive to benralizumab (Fasenra), among patients with severe, uncontrolled asthma with eosinophilic inflammation.
Obesity a Major Preventable Risk Factor for Asthma in Children
November 30th 2018

Obesity a Major Preventable Risk Factor for Asthma in Children

Jackie Syrop
A new study in Pediatrics concludes that 23%-27% of new asthma cases in children with obesity is directly attributable to obesity, and without overweight and obesity as a factor there would be 10% fewer cases of pediatric asthma in the United States.
Nurse-Led Cognitive Behavioral Therapy Cost-Effective in COPD
November 27th 2018

Nurse-Led Cognitive Behavioral Therapy Cost-Effective in COPD

Jackie Syrop
Cognitive behavioral therapy delivered by respiratory nurses can reduce anxiety and is cost-effective in patients with chronic obstructive pulmonary disease (COPD).
ICER Report Estimates 50% Discount for Asthma Biologics to Be Cost-Effective
November 24th 2018

ICER Report Estimates 50% Discount for Asthma Biologics to Be Cost-Effective

Jackie Syrop
There are 5 FDA-approved monoclonal antibody treatments that affect the pathways involved in either the allergic or type 2 inflammatory phenotypes of asthma, and these 5 drugs are the focus of a new report from the Institute for Clinical and Economic Review (ICER).
Endothelial Microparticles as Predictive Biomarkers for COPD Exacerbations
November 20th 2018

Endothelial Microparticles as Predictive Biomarkers for COPD Exacerbations

Jackie Syrop
A new study, published in the International Journal of COPD, concludes that the increase in endothelial microparticles and various microparticles in the systemic circulation that accompanies chronic obstructive pulmonary disease (COPD) can lead to disease exacerbation and could be used as early biomarkers on disease progression.
FDA Takes Steps to Prevent Access to Flavored Tobacco Products, Ban Menthol Cigarettes
November 16th 2018

FDA Takes Steps to Prevent Access to Flavored Tobacco Products, Ban Menthol Cigarettes

Jackie Syrop
The FDA today announced new actions aimed at reversing the increasing trend of youth nicotine use and combating youth access to e-cigarettes. Though the agency stopped short of an expected ban on flavored e-cigarettes, it will move to outlaw menthol cigarettes and flavored cigars, 2 products that disproportionately harm African Americans.
Most Patients With CF May Get Insufficient Antibiotics to Fight Lung Infections
November 14th 2018

Most Patients With CF May Get Insufficient Antibiotics to Fight Lung Infections

Jackie Syrop
A new study by Children’s National Health System researchers suggests that the majority of patients with cystic fibrosis (CF) may not achieve blood concentrations of antibiotics sufficiently high enough to effectively fight bacteria causing pulmonary exacerbations.
Hoping to Fend Off FDA, Juul to Stop Selling Certain e-Cig Flavors, For Now
November 14th 2018

Hoping to Fend Off FDA, Juul to Stop Selling Certain e-Cig Flavors, For Now

Allison Inserro
Facing the threat of impending US regulatory action, Juul Labs said Tuesday it would voluntarily stop selling certain flavors of its flavored e-cigarettes in retail stores on a temporary basis, but would continue to sell them online, and plans to improve its age-verification system.
ALA, ATS Seek Increase in Lung Cancer Screenings With New Healthcare Guide
November 13th 2018

ALA, ATS Seek Increase in Lung Cancer Screenings With New Healthcare Guide

Allison Inserro
An estimated 25,000 Americans who are at high risk for developing lung cancer would be saved annually through low-dose computed tomography (CT) scans, but only 5% of people who qualify are screened. In an effort to increase the number of people getting screened, the American Lung Association (ALA) and the American Thoracic Society (ATS) unveiled a Lung Cancer Screening Implementation Guide during Lung Cancer Awareness Month.
Secondhand Exposure to Electronic Nicotine Delivery Systems Linked to Asthma Symptoms in Youth
November 11th 2018

Secondhand Exposure to Electronic Nicotine Delivery Systems Linked to Asthma Symptoms in Youth

Jackie Syrop
A new study in Chest has identified a correlation between electronic nicotine delivery systems (ENDS) and asthma symptoms in youth. The association was independent of cigarette smoking and ENDS use and exposure to secondhand cigarette smoke.
Prevalence of Showerhead Bacteria Correlates With Prevalence of NTM Lung Infections
November 6th 2018

Prevalence of Showerhead Bacteria Correlates With Prevalence of NTM Lung Infections

Jackie Syrop
A study published in the journal mBio has found a correlation between regions where mycobacteria are most prevalent in showerhead biofilm and regions where nontuberous mycobacterial (NTM) lung infections are the most prevalent, providing more evidence about the important role played by showerheads in transmission of NTM lung infections in the United States and Europe.
Oxygenation Strategies May Not Be Most Effective for Treating Acute Hypoxemic Respiratory Failure, Study Finds
November 4th 2018

Oxygenation Strategies May Not Be Most Effective for Treating Acute Hypoxemic Respiratory Failure, Study Finds

Alison Rodriguez
A study that examined mortality among immunocompromised patients with acute hypoxemic respiratory failure found that high-flow oxygen therapy did not significantly decrease 28-day mortality compared with standard oxygen therapy.
5 Updates on Lung Cancer Mortality, Risk, and Treatment
November 2nd 2018

5 Updates on Lung Cancer Mortality, Risk, and Treatment

Jaime Rosenberg
November marks Lung Cancer Awareness Month, which seeks to put a spotlight on the leading cause of cancer death. Here are 5 things to know about the disease.
Flavorants and Propylene Glycol From e-Cigarettes Form Harmful Irritants When Combined
November 2nd 2018

Flavorants and Propylene Glycol From e-Cigarettes Form Harmful Irritants When Combined

David Bai
The mixture of flavorants and propylene glycol (PG) in electronic cigarettes (e-cigs) leads to the formation of acetals that have been shown to activate irritation receptors, predisposing users to the same potential dangers as using traditional cigarettes, a new study said.
Electronic Cigarettes May Cause Same Lung Injuries, Respiratory Changes as Classic Cigarettes
October 26th 2018

Electronic Cigarettes May Cause Same Lung Injuries, Respiratory Changes as Classic Cigarettes

David Bai, PharmD
Electronic cigarettes can cause detrimental effects to human health and should be reconsidered as a smoking cessation tool, based on results from a recent study.
Study Evaluates Healthcare Utilization and Expenditures for Patients With NTM
October 25th 2018

Study Evaluates Healthcare Utilization and Expenditures for Patients With NTM

Alison Rodriguez
Patients with nontuberculous mycobacterial lung disease (NTMLD) have a significant greater risk of hospitalization and higher total healthcare expenditures than matched control patients without NTMLD.
Second Biologic to Make Entry for Moderate-to-Severe Asthma
October 24th 2018

Second Biologic to Make Entry for Moderate-to-Severe Asthma

Allison Inserro
The FDA’s approval of dupilumab, already approved for severe eczema, for asthma makes it the second biologic for the incurable lung disease.
Muscle Relaxants During Anesthesia May Increase Risk of Postoperative Pulmonary Complications
October 20th 2018

Muscle Relaxants During Anesthesia May Increase Risk of Postoperative Pulmonary Complications

Alison Rodriguez
Neuromuscular blocking agents, or muscle relaxants, are often used in surgery to prevent muscles from moving when a patient is unconscious. A recent study found that the use of neuromuscular blockers during general anesthesia is associated with an increased risk of postoperative pulmonary complications.
Dupilumab Shows Positive Results for Chronic Rhinosinusitis With Nasal Polyps
October 17th 2018

Dupilumab Shows Positive Results for Chronic Rhinosinusitis With Nasal Polyps

Allison Inserro
With a decision from the FDA for its use in moderate-to-severe asthma expected by the end of the week, the biologic dupilumab showed positive results from a pivotal phase 3 trial for inadequately controlled chronic rhinosinusitis with nasal polyps.
FDA Label Rule Change Gives Prescribers More Detail for Pregnant Women With Asthma
October 17th 2018

FDA Label Rule Change Gives Prescribers More Detail for Pregnant Women With Asthma

David Bai, PharmD
Treating lung conditions like asthma in pregnant women is a challenge, as it requires knowledge of both the safety of treatments during pregnancy as well as understanding the risks of the disease for both the woman and the infant, noted a review of a new Food and Drug Administration (FDA) information system for prescribers.
FDA Inquiring If Some e-Cigarette Makers Are Selling Devices Without Approval
October 13th 2018

FDA Inquiring If Some e-Cigarette Makers Are Selling Devices Without Approval

Allison Inserro
The FDA said Friday it is asking 21 e-cigarette companies for more information about whether more than 40 products, including some flavored e-cigarette products, are being illegally marketed and are outside the agency’s current compliance policy. The move comes a month after the agency warned of a teen vaping epidemic and said it would be cracking down on the sale of the devices to kids.
<1
...
131415161718192021>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo